e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Pierre-Régis Burgel, Gil Bellis, J. Stuart Elborn
Source:
Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Journal Issue:
August
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pierre-Régis Burgel, Gil Bellis, J. Stuart Elborn. Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis. Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry
Source: Eur Respir J, 55 (1) 1901667; 10.1183/13993003.01667-2019
Year: 2020
The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Genetic characterization of cystic fibrosis patients in Portugal
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Modelling and simulation of experimental designs to find the best design of randomized clinical trials in a rare disease: Cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
The changing epidemiology of cystic fibrosis in Italy: data from the Italian registry
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
The role of
CFTR/ENaC
genotype in cystic fibrosis-like phenotypes
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Cystic fibrosis: paediatric
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Cystic fibrosis: paediatric
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Cystic fibrosis: paediatric
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Cystic fibrosis: paediatric
Source: ERS Skills Course 2016
Year: 2016
Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept